ClinicalTrials.Veeva

Menu

Observation of Environment and Reproductive-Endocrine Effects

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Enrolling

Conditions

Precocious Puberty
Late Puberty
Amenorrhea
Hypergonadism
Hypogonadism

Study type

Observational

Funder types

NIH

Identifiers

NCT06280807
10001617
001617-E

Details and patient eligibility

About

Background:

Endocrine disorders occur when the glands that make hormones do not work properly. Hormones levels that are too high or too low can cause problems such as late or early puberty, irregular periods, and infertility. Environmental factors - including pollution; chemical exposure at home and work; foods; medicines; and sleep habits - may cause problems with the endocrine and reproductive systems.

Objective:

To learn how environmental factors may affect the endocrine and reproductive systems.

Eligibility:

Males or females, referring to sex assigned at birth, aged 8 years and older; they must have hypogonadism, infertility, or other reproductive disorders.

Design:

Adult participants will have 4 to 5 visits in 5 years. Children may have up to 12 visits; they may remain in the study up to the age of 23. Most visits will be less than 3 hours.

Participants will be screened. They will have a physical exam. They will have blood and urine tests. They will complete questionnaires; they will answer questions about their diet, health, and other topics. Some may be referred for additional tests, such as imaging scans and semen analysis.

Specific tests conducted during study visits will vary, depending on the participant s diagnosis. In addition to repeated blood and urine tests, these may include:

Body composition measure: Participants will sit in a pod-shaped machine for about 6 minutes. The machines measures the air inside the capsule to record body fat and breathing volume.

Resting energy expenditure test: Participants will lie down with a clear dome placed over their head. They will breathe quietly for 30 minutes. This test measures the number of calories their body burns at rest.

...

Full description

Study Description:

This study will investigate the relationship between environment, lifestyle, and reproductive function. This will include the study of these factors at enrollment and in response to clinical care for the underlying condition. This study will prospectively follow participants with endocrine reproductive disorders and collect data secondary to clinical care and data regarding internal and external environmental exposures. We hypothesize that dysregulated environment is associated with reproductive and endocrine dysfunction and the clinical phenotype may evolve in response to treatment of the dysfunction. To study the hypothesis that external and internal environmental factors are associated with reproductive and endocrine dysfunction.

Objectives:

  • To study the hypothesis that external and internal environmental factors are associated with reproductive and endocrine dysfunction
  • To generate hypothesis for future studies investigating the impact of environment on human health

Endpoints:

Since this is an exploratory and hypothesis generating study there are no pre-defined endpoints of this study.

Enrollment

300 estimated patients

Sex

All

Ages

8 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  1. Male or female, referring to sex assigned at birth (cis gender)

  2. Age > 8 years and weight >= 12 kg

  3. A diagnosis of hypogonadism, infertility or other reproductive dysfunction

    Some specific diagnoses (as defined in standard guidelines) will include:

    • Male or female hypogonadism

      • Obesity/metabolic syndrome related to hypogonadism.
      • Other reproductive dysfunction (e.g., secondary to endocrine dysfunction, thyroid disorders, Cushing syndrome, pharmacotherapy, etc.)
      • Premature Ovarian Insufficiency
      • Isolated hypogonadotropic hypogonadism
    • Polycystic Ovarian Syndrome

    • Delayed Puberty

    • Precocious puberty

    • Perimenopause and post-menopausal states

    • Androgen Excess States (Nonclassic Congenital Adrenal Hyperplasia, Extreme hyperinsulism, Idiopathic etc.)

    or

    -Exhibiting signs of a diagnosis of hypogonadism, e.g., Bosma arrhinia microphthalmia syndrome (BAMS)

  4. Ability of participant, legal guardian, or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document.

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

  1. A diagnosis of a serious medical disorder such as malignancy or heart disease will be grounds for exclusion at the discretion of the PI or AI.
  2. Inability to follow up with the research study and/or perform study procedures, at the discretion of the PI or AI.
  3. Pregnant participants, less than 18 years of age, for their safety, since there is not a trained doctor on the study to give proper medical care to pregnant individuals less than 18 years of age.

Individuals who do not meet the criteria for participation in this study (screen failure) because of an acute, reversible or transient medical reason may be rescreened upon reversal, improvement or stabilization of their clinical status. Participants who develop an acute, reversible or transient medical condition during the study may return upon reversal, improvement or stabilization of their clinical status.

Trial design

300 participants in 9 patient groups

Androgen Excess States
Description:
Polycystic Ovary Syndrome (PCOS);Women who meet criteria for PCOS based on NIH/ Rotterdam or other clinical criteria
Congenital Adrenal Hyperplasia / Hyperandrogenism
Description:
Women who exhibit evidence of hyperandrogenism not related to Polycystic Ovarian Syndrome (PCOS); Nonclassic Congenital Adrenal Hyperplasia, Extreme hyperinsulism, Idiopathic etc.
Exhibiting signs of a diagnosis of hypogonadism
Description:
for example: Bosma arrhinia microphthalmia syndrome (BAMS)
Hypogonadism / Infertility
Description:
Isolated hypogonadotropic hypogonadism
Hypothalamic Amenorrhea (HA) (female) Functional Hypogonadism (male)
Description:
Participants who experience secondary or primary amenorrhea, or male hypogonadism, in the setting of negative energy balance such dieting, eating disorders or exercise training
Miscellaneous
Description:
Reproductive disorders not related to the above categories. (e.g., secondary to endocrine dysfunction, thyroid disorders, Cushing syndrome, pharmacotherapy, etc.)
Precocious or Delayed Puberty
Description:
Participants who display clinical evidence of delayed or precocious puberty based on standard criteria.
Premature Ovarian InsufficiencyPerimenopause or post-menopausal states
Description:
Women who attain menopause before age 40 years (or as defined by clinical criteria). Perimenopausal women are those typically above age 40 years and experience secondary amenorrhea/ oligomenorrhea.
Weight *Overweight/Underweight
Description:
BMI below or above reference standard (Adult Reference: Asians/ Asian Americans- 18.5-22.9 kg/m2; Other races- 18.5-24.9 kg/m2\*Participants may simultaneously belong to cohort of weight and any other cohort.

Trial contacts and locations

1

Loading...

Central trial contact

Skand Shekhar, M.D.; NIEHS Join A Study Recruitment Group

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems